Alivus Life Sciences Limited - PE Ratio

The PE Ratio as of October 2026 (TTM) for Alivus Life Sciences Limited (ALIVUS.NS) is 26.51

According to Alivus Life Sciences Limited’s latest financial reports and current stock price. The company's current PE Ratio is 26.51. This represents a change of 30.57% compared to the average of 20.30 of the last 4 quarters.

Alivus Life Sciences Limited (ALIVUS.NS) Historical PE Ratio (quarterly & annually)

How has ALIVUS.NS PE Ratio performed in the past?

The mean historical PE Ratio of Alivus Life Sciences Limited over the last ten years is 23.63. The current 26.51 PE Ratio has changed 11.12% with respect to the historical average. Over the past ten years (40 quarters), ALIVUS.NS's PE Ratio was at its highest in in the September 2024 quarter at 31.77. The PE Ratio was at its lowest in in the March 2024 quarter at 0.

Alivus Life Sciences Limited (ALIVUS.NS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alivus Life Sciences Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alivus Life Sciences Limited (ALIVUS.NS) Average PE Ratio

How has ALIVUS.NS PE Ratio performed in the past?

The current PE Ratio of Alivus Life Sciences Limited (ALIVUS.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Alivus Life Sciences Limited (ALIVUS.NS) PE Ratio vs. Peers

How is ALIVUS.NS’s PE Ratio compared to its peers?

Alivus Life Sciences Limited’s PE Ratio is greater than Alembic Pharmaceuticals Limited (22.70), less than Ipca Laboratories Limited (37.54), greater than NATCO Pharma Limited (12.45), less than Cohance Lifesciences Limited (104.83), greater than Bal Pharma Limited (21.19), less than Morepen Laboratories Limited (53.34), less than Laurus Labs Limited (98.66), less than Granules India Limited (30.12), less than SMS Pharmaceuticals Limited (39.75), less than Aarti Pharmalabs Limited (37.39),

Build a custom stock screener for Alivus Life Sciences Limited (ALIVUS.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alivus Life Sciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alivus Life Sciences Limited (ALIVUS.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alivus Life Sciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.